Hepatocellular carcinoma subtypes based on metabolic pathways reveals potential therapeutic targets

Hepatocellular carcinoma subtypes based on metabolic pathways reveals potential therapeutic targets

IntroductionHepatocellular carcinoma (HCC) is an aggressive malignancy with steadily increasing incidence rates worldwide and poor therapeutic outcomes. Studies show that metabolic reprogramming plays a key role in tumor genesis and progression. In this study, we analyzed the metabolic heterogeneity...

Full description

Bibliographic Details
Main Authors: Zehua He, Qingfeng Chen, Wanrong He, Junyue Cao, Shunhan Yao, Qingqiang Huang, Yu Zheng
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-03-01
Series:Frontiers in Oncology
Subjects:
hepatocellular carcinoma (HCC)
metabologenomics
bioinformatics
microenvironment
targeted therapy
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2023.1086604/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2023.1086604/full

Similar Items